I-University of Texas MD MD Anderson Cancer Center kanye ne-Takeda Pharmaceutical Company Limited bangene ekuqondeni okulinganiselwe kanye nemvume yocwaningo ukuze kuthuthukiswe futhi kumakethwe isamukeli se-chimeric antigen esiqondiswe ngombulali wemvelo (CAR.